Danhong Injection in the Treatment of Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1503 participants.
Also called NCT01677208
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,503 participants
- Registry
-
NCT01677208
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01677208. Randomized; quadruple masking; primary purpose treatment. Start 2013-03-13 (actual); primary completion 2019-03-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Danhong Injection in the Treatment of Acute Ischemic Stroke
- Condition
- Acute Stroke
- Intervention (Drug)
- Danhong injection
- Intervention (Procedure)
- Standard medical care
- Intervention (Drug)
- placebo
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Collaborator
- China Food and Drug Administration
Record details
- Record id
cardio:ct-nct01677208- Content hash
272e0c234c00ce4214fa09494632c3ad791baf261df1d2b6917f30d7bbd8b617